T-cell Receptor (TCR) therapy

The Parker Foundation today announced a $250 million grant to launch the Parker Institute for Cancer Immunotherapy, a collaboration between many of the country's best scientists, clinicians and industry partners to lead an unprecedented cancer immunotherapy research effort. The gift is the largest single contribution ever made to the field of immunotherapy. The Parker Institute's goal is to accelerate the development of breakthrough immune therapies capable of turning cancer into a curable disease by ensuring the coordination and collaboration of the field's top researchers and quickly translating their findings into patient treatments.

Read More »